Intervention

Part C2: Abiraterone acetate combination with AZD8186

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

1 shown

AZD8186 First Time In Patient Ascending Dose StudyNCT01884285 · 2013-07-09

COMPLETED

Common conditions

Advanced Castrate-resistant Prostate Cancer CRPC1 Squamous Non-Small Cell Lung Cancer sqNSCLC1 Triple Negative Breast Cancer TNBC1

Leading sponsors

AstraZeneca1

Trial status mix

COMPLETED1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.